Senthilkumar Preethy, Shuji Sakamoto, Takuma Higuchi, Koji Ichiyama, Naoki Yamamoto, Nobunao Ikewaki, Masaru Iwasaki, Vidyasagar Devaprasad Dedeepiya, Subramaniam Srinivasan, Kadalraja Raghavan, et al. Enhanced expression of dystrophin, IGF-1, CD44 and MYH3 in plasma and skeletal muscles including diaphragm of mdx mice after oral administration of Neu REFIX beta 1,3-1,6 glucan. Scientific reports. 2025. 15. 1. 7232-7232
Subramanian Pushkala, Sudha Seshayyan, Ethirajan Theranirajan, Doraisamy Sudhakar, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Senthilkumar Preethy, Samuel Jk Abraham. Efficient Control of IL-6, CRP and Ferritin in COVID-19 Patients With Two Variants of Beta-1,3-1,6 Glucans in Combination: An Open-Label, Prospective, Randomised Clinical Trial. Global advances in integrative medicine and health. 2025. 14. 27536130251327134-27536130251327134
Nobunao Ikewaki, Koji Ichiyama, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel J K Abraham. Commentary: The ME-BYO index: A development and validation project of a novel comprehensive health index. Frontiers in public health. 2024. 12. 1495056-1495056
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Subramaniam Srinivasan, Subramanian Pushkala, Sudhakar S Bharatidasan, Nobunao Ikewaki, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel J K Abraham. Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study. IBRO neuroscience reports. 2023. 15. 90-99
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Subramaniam Srinivasan, Subramanian Pushkala, Sudhakar S Bharatidasan, Nobunao Ikewaki, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel J K Abraham. Corrigendum to "Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study" [IBRO Neurosci. Rep. 15 (2023), pp. 90-99]. IBRO neuroscience reports. 2023. 15. 149-150
池脇 信直, 園田 徹, 宮澤 靖, 近森 正幸. Sophy β-glucan (β-1,3-1,6 glucan)摂取後の特異抗体と免疫バイオマーカーの解析. 九州保健福祉大学研究紀要 = Journal of Kyushu University of Health and Welfare. 2020. 21. 67-72
池脇 信直, 園田 徹, 東 和弘, いけわき のぶなお, そのだ とおる, あずま かずひろ, Nobunao IKEWAKI, Tohru SONODA, Kazuhiro AZUMA. 水素ガスを含む蒸気混合ガス吸入後のインフルエンザウイルス由来のhemagglutinin抗原に対する唾液中IgA抗体価の増強. 九州保健福祉大学研究紀要 = Journal of Kyushu University of Health and Welfare. 2019. 20. 69-74
池脇 信直, 園田 徹, 宮澤 靖, 鬼塚 信, 近森 正幸, いけわき のぶなお, そのだ とおる, みやざわ やすし, おにづか しん, ちかもり まさゆき, et al. 健常人におけるβ-1,3-1,6 glucan特異抗体と免疫バイオマーカーの血清レベル. 九州保健福祉大学研究紀要 = Journal of Kyushu University of Health and Welfare. 2018. 19. 87-94
池脇 信直, 園田 徹, 東 和弘, いけわき のぶなお, Nobunao IKEWAKI. 水素ガスを含む蒸気混合ガス吸入後の唾液バイオマーカーの解析. 九州保健福祉大学研究紀要 = Journal of Kyushu University of Health and Welfare. 2017. 18. 67-72